Cost-Effectiveness of a Novel Molecular Test for Cytologically Indeterminate Thyroid Nodules | Zendy

Henry Li | Zendy; Karen A. Robinson | Zendy; Blair Anton | Zendy; Ian J. Saldanha | Zendy; Paul W. Ladenson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-Effectiveness of a Novel Molecular Test for Cytologically Indeterminate Thyroid Nodules

Author(s) -

Henry Li,

Karen A. Robinson,

Blair Anton,

Ian J. Saldanha,

Paul W. Ladenson

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-0459

Subject(s) - indeterminate , thyroid nodules , medicine , cost effectiveness , reimbursement , test (biology) , quality adjusted life year , biopsy , thyroid , radiology , surgery , health care , mathematics , risk analysis (engineering) , paleontology , pure mathematics , biology , economics , economic growth

Determining which patients with thyroid nodules require surgery is limited by cytologically indeterminate findings. A new approach for preoperative molecular classification of cytologically indeterminate thyroid nodules has a reported sensitivity of 91% and specificity of 75%; however, its cost-effectiveness has yet to be assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research